Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heinrich Wieland

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|February 9, 2008
Elimination of liposomes by different separation principles used in low-density lipoprotein apheresisGerhard Pütz, Jürgen Eckes, Oliver Schmah, et al.
Heart and Vessels|May 25, 2002
A free fatty acid tolerance test identifies patients with coronary artery disease among individuals with a low conventional coronary risk profileSabine Westphal, Günther Helmut Gekeler, Jutta Dierkes, et al.
Analytical Biochemistry|January 15, 2005
Reference values for serum silicon in adultsEmmanuel Bissé, Thomas Epting, Annette Beil, et al.
Contraception|February 5, 2004
Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 microg or 30 microg) and levonorgestrel (100 microg or 150 microg) on lipoprotein metabolismHubert Scharnagl, Gudula Petersen, Matthias Nauck, et al.
The American Journal of Cardiology|January 13, 2004
Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterolHubert Scharnagl, Manfred Kist, Andrea Busse Grawitz, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Fluvastatin slow-release lowers platelet-activating factor acetyl hydrolase activity: a placebo-controlled trial in patients with type 2 diabetesKarl Winkler, Claudia Abletshauser, Isolde Friedrich, et al.
Journal of the American Society of Nephrology : JASN|February 22, 2001
Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathyMichael M Hoffmann, Hubert Scharnagl, Eleftheria Panagiotou, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 20, 2002
The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarctionMarkus Nauck, Bernhard R Winkelmann, Michael M Hoffmann, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Effect of fluvastatin slow-release on low density lipoprotein (LDL) subfractions in patients with type 2 diabetes mellitus: baseline LDL profile determines specific mode of actionKarl Winkler, Claudia Abletshauser, Michael M Hoffmann, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 17, 2019
Role of human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C3) in the extrahepatic metabolism of the steroidal aromatase inactivator FormestaneRunlan Wan, Xi Kong, Youzhe Yang, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|February 9, 2008
Elimination of liposomes by different separation principles used in low-density lipoprotein apheresisGerhard Pütz, Jürgen Eckes, Oliver Schmah, et al.
Heart and Vessels|May 25, 2002
A free fatty acid tolerance test identifies patients with coronary artery disease among individuals with a low conventional coronary risk profileSabine Westphal, Günther Helmut Gekeler, Jutta Dierkes, et al.
Analytical Biochemistry|January 15, 2005
Reference values for serum silicon in adultsEmmanuel Bissé, Thomas Epting, Annette Beil, et al.
Contraception|February 5, 2004
Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 microg or 30 microg) and levonorgestrel (100 microg or 150 microg) on lipoprotein metabolismHubert Scharnagl, Gudula Petersen, Matthias Nauck, et al.
The American Journal of Cardiology|January 13, 2004
Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterolHubert Scharnagl, Manfred Kist, Andrea Busse Grawitz, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Fluvastatin slow-release lowers platelet-activating factor acetyl hydrolase activity: a placebo-controlled trial in patients with type 2 diabetesKarl Winkler, Claudia Abletshauser, Isolde Friedrich, et al.
Journal of the American Society of Nephrology : JASN|February 22, 2001
Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathyMichael M Hoffmann, Hubert Scharnagl, Eleftheria Panagiotou, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 20, 2002
The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarctionMarkus Nauck, Bernhard R Winkelmann, Michael M Hoffmann, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Effect of fluvastatin slow-release on low density lipoprotein (LDL) subfractions in patients with type 2 diabetes mellitus: baseline LDL profile determines specific mode of actionKarl Winkler, Claudia Abletshauser, Michael M Hoffmann, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 17, 2019
Role of human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C3) in the extrahepatic metabolism of the steroidal aromatase inactivator FormestaneRunlan Wan, Xi Kong, Youzhe Yang, et al.
Pageof 3